Skip to main content
POOLBEG PHARMA PLC logo

POOLBEG PHARMA PLC — Investor Relations & Filings

Ticker · POLB ISIN · GB00BKPG7Z60 LEI · 213800UZ8WJLWYHBFL52 IL Manufacturing
Open in API
Filings indexed 160 across all filing types
Latest filing 2025-05-27 Regulatory Filings
Country GB United Kingdom
Listing IL POLB

About POOLBEG PHARMA PLC

https://poolbegpharma.com/

Poolbeg Pharma PLC is a clinical-stage biopharmaceutical company that develops and commercializes medicines for diseases with high unmet medical needs. The company's lead asset, POLB 001, is a treatment designed to prevent Cytokine Release Syndrome (CRS), a severe side effect associated with cancer immunotherapies, with the aim of making these treatments safer and more accessible. Poolbeg is also advancing an oral GLP-1 program for obesity, offering a patient-friendly therapeutic option. The company utilizes an artificial intelligence (AI)-led discovery platform that analyzes data from human challenge trials to identify novel drug targets. This AI-driven approach aims to accelerate target identification, reduce costs, and lower development risks.

Recent filings

Filing Released Lang Actions
FDA Orphan Drug Designation granted for POLB 001
Regulatory Filings Classification · 1% confidence The document is clearly identified as originating from 'RNS Number : 0878K' and contains the standard footer information for RNS (Regulatory News Service) announcements from the London Stock Exchange. The content announces a specific corporate event: the granting of Orphan Drug Designation (ODD) by the FDA for a drug candidate (POLB 001). This type of material—a specific, material, non-periodic corporate update disseminated via an official news service—fits best under the general 'Regulatory Filings' category, as it is not a full financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a specific insider trade (DIRS). While it is a material announcement, it doesn't fit the highly specific categories like DIV, CAP, or MANG. Therefore, RNS is the most appropriate classification for this type of general regulatory news release.
2025-05-27 English
Annual Report, AGM Notice & Circular
AGM Information Classification · 1% confidence The document explicitly states it confirms that the 'Annual Report and Accounts for the period ended 31 December 2024 and the notice of Annual General Meeting ("AGM") will be posted to shareholders today.' It also mentions a 'Circular containing details of the Fundraising and convening a general meeting'. Since the document is an announcement confirming the release and posting of the Annual Report, AGM Notice, and Circular, and it is distributed via RNS (London Stock Exchange news service), it fits the description of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given the specific mention of the Annual Report and AGM Notice being posted, and the document structure being a brief announcement rather than the full report itself (length is 7166 chars, but the content is primarily an announcement), RPA is a strong candidate. However, because it bundles the Annual Report, AGM Notice, and a Circular, and is distributed through RNS, it is best classified as a general Regulatory Filing (RNS) or potentially a combination announcement. Since the primary action is announcing the availability of the Annual Report and AGM materials, and it is clearly an RNS release, RNS is the most appropriate general category for this type of regulatory news service announcement, although RPA is also highly relevant. Given the presence of 'Annual Report' and 'AGM Notice' being posted, and the document being an RNS release, I will select RNS as the fallback for this combined announcement type, though AGM-R or RPA are close contenders. Upon review, the document is an RNS announcement that *contains* the AGM Notice and Annual Report information, making RNS the most accurate classification for the announcement itself.
2025-05-27 English
Result of upsized oversubscribed BookBuild Offer
Capital/Financing Update Classification · 1% confidence The document is an official announcement released via RNS (RNS Number : 8784J) on May 23, 2025. The title explicitly states 'Result of upsized and oversubscribed BookBuild Offer' and details the gross proceeds raised (£150,000 from the BookBuild Offer, totaling £4.865 million from the overall Fundraising). This announcement concerns a capital raising/financing activity involving the issuance of new shares ('BookBuild Offer Shares'). This clearly falls under the definition of Capital/Financing Update (CAP). Although it is a regulatory announcement (RNS), the specific nature of the content (result of a fundraising) makes CAP the most precise classification. It is not a short announcement merely pointing to an attached report, but the report of the financing result itself.
2025-05-23 English
Increase of BookBuild Offer
Capital/Financing Update Classification · 1% confidence The document is an official announcement from Poolbeg Pharma PLC regarding an increase in the size of a 'BookBuild Offer' (a capital raising activity). It details the number of shares being offered, the intended use of proceeds, and the timeline for admission to trading on the AIM market. This falls under the category of company fundraising and financing activities.
2025-05-22 English
Result of Placing and Notice of General Meeting
Capital/Financing Update Classification · 1% confidence The document is an official announcement from Poolbeg Pharma PLC regarding a 'Result of Placing' and 'Notice of General Meeting'. It details the successful raising of capital through a share placing and subscription, outlines the use of proceeds, and mentions the upcoming publication of a circular for a general meeting. This falls under the category of capital and financing updates as it describes the company's fundraising activities and share issuance.
2025-05-20 English
Proposed Retail Offer to raise up to £100,000
Capital/Financing Update Classification · 1% confidence The document is an official announcement from Poolbeg Pharma PLC regarding a 'Proposed Retail Offer' to raise capital through the issuance of new ordinary shares. It details the fundraising terms, the purpose of the funds, the timeline, and the eligibility criteria for shareholders. This falls under the category of capital raising and financing activities, specifically fitting the 'Capital/Financing Update' classification.
2025-05-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.